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Interfaces between organelles are emerging as critical platforms for many biological
responses in eukaryotic cells. In yeast, the ERMES complex is an endoplasmic reticulum
(ER)–mitochondria tether composed of four proteins, three of which contain a SMP
(synaptotagmin-like mitochondrial-lipid binding protein) domain. No functional ortholog
for any ERMES protein has been identified in metazoans. Here, we identified PDZD8 as an
ER protein present at ER-mitochondria contacts.The SMP domain of PDZD8 is functionally
orthologous to the SMP domain found in yeast Mmm1. PDZD8 was necessary for the
formation of ER-mitochondria contacts in mammalian cells. In neurons, PDZD8 was
required for calcium ion (Ca2+) uptake by mitochondria after synaptically induced
Ca2+-release from ER and thereby regulated cytoplasmic Ca2+ dynamics. Thus, PDZD8
represents a critical ER-mitochondria tethering protein in metazoans. We suggest that
ER-mitochondria coupling is involved in the regulation of dendritic Ca2+ dynamics in
mammalian neurons.
C
ontacts between the endoplasmic reticulum
(ER) and the mitochondria are thought to
represent a signaling hub where Ca2+ and
lipid exchange can occur between these two
organelles (1, 2). In addition, changes in the
extent of ER-mitochondria contacts have been
reported in various models of neurodegenerative
diseases such asAlzheimer’s disease (3–5). Several
proteins that are enriched at ER-mitochondria in
mammalian cells, includingMitofusin2, have been
proposed to play a role inmodulating the contacts
between these organelles (6–9). However, muta-
tion of the genes encoding these proteins has
complex and sometimes contradictory pheno-
typic consequences on ER-mitochondria contacts
(10–12).
The ER–mitochondria encounter structure
(ERMES) complex functions as a tether between
the ER and mitochondria in budding yeast (1).
Three out of four ERMES complex proteins
(Mmm1, Mdm12, and Mdm34) contain an SMP
domain. Trans-heterodimerization of SMP do-
mains within proteins such as extended synap-
totagmin 2 (E-syt2) was recently proposed to
participate in lipid exchange between ER and
plasma membrane (13–15). Based on low levels
of amino acid sequence homology, no ERMES
complex ortholog has been identified in meta-
zoans (16, 17) (fig. S1, C to E). Recent bioinformat-
ics approaches predicted the existence of several
SMP domain–containing proteins in metazoans
(18, 19), including a protein of unknown func-
tion called PDZD8. A search of the PDB (Protein
Data Bank) using the Phyre2 protein modeling
server showed that the SMP-containing proteins
E-syt2 (PDB code 4P42) and the ERMES complex
protein Mdm12 (PDB code 5gyk), respectively,
are similar to residues 92 to 367 and 105 to 287 of
PDZD8 with >99.8% confidence [expected value
of <10−26 in hidden Markov models (HMM)-
HMM–based lightning-fast iterative sequence
search (HHBLITS)] (Fig. 1, B and C). Furthermore,
there is a high correspondence in the second-
ary structure elements (SSEs) of the predicted
SMP domain of PDZD8 and the actual SSEs in
the SMP domains of E-syt2 and Mdm12 (Fig. 1D).
These results strongly suggest that PDZD8 is
an SMP-containing protein. We therefore explored
the possibility that PDZD8 constitutes a structural
and functional ortholog of the ERMES compo-
nent Mmm1.
Investigating the functional similarity
between the SMP domains of Mmm1
and PDZD8
Mmm1 and PDZD8 contain an N-terminal trans-
membrane domain followed by an SMP domain,
although PDZD8 has a longer C-terminal exten-
sion, including predicted PDZ, C1, and coil-coiled
(CC) domains (Fig. 1A). In addition, Mmm1 is the
only SMP-containing ERMES subunit localized
to the ER in yeast (1, 20). Modeling indicated that
the predicted SMP domains of PDZD8 and Mmm1
are structurally homologous with the SMP do-
mains of E-syt2 and Mdm12 (Fig. 1, B and C, and
fig. S1, A to C). To determine whether PDZD8 and
Mmm1 are functionally homologous, we first ex-
pressed PDZD8 in yeast and tested its localization.
PDZD8-Venus colocalized with yeast ER-resident
protein Pho88, suggesting conserved and func-
tional ER targeting of PDZD8 (fig. S2A).
Next, we investigated whether PDZD8 could
functionally complement for Mmm1 function.
Deletion of the MMM1 gene resulted in critical
cellular and mitochondrial defects, including
(i) the collapse of the mitochondrial tubular
network into one or two large spherical struc-
tures, (ii) severe mitochondrial inheritance defects
during cell division, and (iii) the complete loss
of mitochondrial DNA (mtDNA) (figs. S3 to S5)
(21, 22). Becausemmm1D cells rapidly accumulate
suppressor mutations (23), we used a plasmid
shuffling experimental strategy to replace endog-
enous MMM1 with genes of interest to avoid ad-
aptation to the loss of MMM1 (fig. S3A). Briefly,
we transformed a low-copy plasmid bearing genes
of interest, including PDZD8 variants under the
MMM1 promoter and a URA3 selectable mark-
er (pRESC), into heterozygous mmm1D/MMM1
diploid cells expressing mitochondria-targeted
Cit1p-mCherry. Haploid cells containing the res-
cue plasmid and a deletion of MMM1 (pRESC +
mmm1D) were generated from the diploids and
analyzed for functional rescue. Finally, to exclude
the possibility of genomic adaptation, we tested
whether the recovered phenotype could be re-
versed by loss of the rescue plasmid through 5-
fluoroorotic acid (5-FOA) incubation, which is
toxic to cells expressing URA3 and selects for
spontaneous loss of pRESC (fig. S3A).
First, we attempted to rescue themmm1Dwith
the truncated formof PDZD8 containing the trans-
membrane and SMP domains (PDZD8TM-SMP) or
the SMP domain-swapped MMM1 with a PDZD8-
SMP domain (pMMM1-SMPPDZD8_full) (fig. S3, B
and C). However, these proteinswere not able to
restore the mitochondrial morphology, inheri-
tance, and mtDNA maintenance defects, unlike
wild-typeMMM1 (fig. S3, B and C).
Structural alignment of the SMP domains of
Mmm1 and PDZD8 or Mdm12 revealed that the
only major differences in SSEs reside within the
two loops of the first b sheet (L1 and L2 for Pdzd8
and L1 for Mdm12) (fig. S1D). Thus, we next tested
an MMM1 SMP-domain swap with PDZD8 that
spared the original L1 and L2MMM1-SMP regions
(pMMM1-SMPPDZD8+L1L2) (fig. S4). Surprisingly,
expression of the yeast MMM1/mouse PDZD8
chimera containing L1 and L2 or MMM1/Mdm12
chimera containing L1 restored (i) retention of
mtDNA in ~25% of cells examined (fig. S4, D
and E), (ii) mitochondrial inheritance in ~50%
of the cells examined (fig. S4, D and F), and (iii)
normal tubular mitochondrial morphology in
~30% of the organelles examined (fig. S4, D and
G; see fig. S5 for the development of the mito-
chondrial morphology quantification method).
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Fig. 1. The SMP domain–containing PDZD8 is a mammalian ortholog
of yeast Mmm1 and is present at ER-mitochondria contact sites.
(A) Domain organization of S. cerevisiae Mmm1 and mammalian PDZD8
proteins. (B and C) Superimposition of Phyre2 structural homology
models for the SMP domains of PDZD8 over the crystal structures of
mammalian E-syt2 (192 to 370 amino acids) (B) or S. cerevisiae Mdm12
(1 to 266 amino acids) (C). Root mean square deviation of atomic
positions (RMSD) values show higher similarity with E-syt2 than
Mdm12 (see fig. S1). (D) Predicted secondary structure of the SMP
domain of PDZD8 (mouse) alignment with E-syt2 (human) and Mdm12
(S. cerevisiae) suggests a high degree of structural homology at the
secondary structural level. Expected value = 3.5 × 10−26 (PDZD8 versus
E-syt2). (E) Western blots of subcellular fractionation from HEK293T cells
demonstrates the presence of endogenous PDZD8 in ER and MAM
fractions. MAM fraction was isolated using a Percoll gradient and
immunoblotted with antibodies to PDZD8, calnexin (for ER and MAM
fractions), and cytochrome C (for mitochondrial fraction). (F to K) We
generated a mouse Neuro2a (N2a) cell line by knockin of Venus in the
endogenous Pdzd8 genomic locus to create a C-terminal fusion PDZD8-
Venus fusion protein by transfecting with a plasmid expressing guide
RNA targeted to PDZD8 sequence and Cas9, together with the donor
plasmid (see fig. S6A for details). N2a cells that had stably integrated
the donor plasmid were enriched by selection with 600 mg/ml Geneticin
(G418 sulfate). The targeted cells were transfected with a plasmid
expressing Canx-mCherry (ER marker) and stained with antibodies to
red fluorescent protein, GFP, and OXPHOS (oxidative phosphorylation)
complex (mitochondrial marker). The stained cells were imaged with
super-resolution microscopy (3D SIM). Images from a single plane [(F) to
(I)] and a 3D reconstructed image (J) are shown. Arrowheads indicate
the localization of PDZD8 at ER-mitochondria contact sites. (K) Analysis
of colocalization between ER and PDZD8-Venus, and mitochondria and
PDZD8-Venus using Mander’s overlap demonstrates PDZD8 localization
with ER but not mitochondria. Data are from four cells in each group.
***P < 0.0005, Student’s t test.













Plasmid loss by 5-FOA reversed the rescue
phenotype (fig. S4).
Despite containing the original L1 and L2 loops
fromMMM1, the SMP domain of the rescue con-
struct (pMMM1-SMPPDZD8+L1L2) consisted of >75%
of the primary sequence found in PDZD8, with
only ~15% sequence identity toMMM1. Moreover,
although the rescue with pMMM1-SMPPDZD8+L1L2
was partial, it was similar to that observed
when the SMP domain of Mmm1 was replaced
with the SMP domain of another ERMES protein,
Mdm12 (fig. S4). Thus, the SMP domain of meta-
zoanPDZD8 is as functional as a yeast SMPdomain.
Thus, SMP domains from yeast MMM1 rep-
resent a structural and functional ortholog of
the SMP domain of metazoans PDZD8. Addition-
ally, we find that functional homology between
MMM1 and PDZD8 SMP domains does not ex-
tend to the L1 and L2 loops. The L1 and L2 loops
are poorly conserved even among the Ascomycota,
such as Schizosaccharomyces pombe,Magnaporthe
oryzae, and Neurospora crassa. Thus, variability
in the L1 and L2 loops may lend specificity of
SMP domains to a particular functional context
in different organisms.
PDZD8 is an ER protein localized at
ER-mitochondria contact sites
Because both Mmm1 and PDZD8 reside in the
ER in Saccharomyces cerevisiae, we examined
the subcellular localization of PDZD8 in mam-
malian cells. PDZD8-HA in HeLa cells showed
extensive colocalization with ER-targeted Calnexin–
yellow fluorescent protein (fig. S2B). To exam-
ine the localization of endogenous PDZD8, we
produced a PDZD8-Venus knockin Neuro2a (N2a)
cell line in which Venus fluorescent protein was
knocked into the PDZD8 genomic locus using
CRISPR-Cas9 (fig. S6A). The endogenous expres-
sion was confirmed by immunofluorescence (Fig. 1,
F to K) and Western blots using antibodies to
PDZD8 and green fluorescent protein (GFP) (fig.
S6, B and C). ER and mitochondria in PDZD8-
Venus knockin N2a (N2aPDZD8-Venus) cells were
labeled by coexpression of Calnexin-mCherry and
staining with an antibody cocktail against mito-
chondrial proteins (OXPHOS). Super-resolution
imaging with structured illumination microscopy
(SIM) revealed that endogenous PDZD8-Venus
was localized in the ER and also found at ER-
mitochondria contact sites (Fig. 1, F to K; fig. S6,
E to H; and movie S1).
Subcellular fractionation of human embryonic
kidney (HEK) 293T cells using antibody to PDZD8
(24) and N2aPDZD8-Venus cells confirmed that
PDZD8 was enriched in the ER and present at
the mitochondria-associated endoplasmic reticu-
lummembrane (MAM) fraction but not detected
in the pure mitochondrial fraction (Fig. 1E and
fig. S6D). Thus PDZD8 is an ER-resident protein
that is also localized at ER-mitochondria con-
tact sites.
PDZD8 is required for formation of
ER-mitochondria membrane contacts
Because PDZD8was present at ER-mitochondria
contact sites and contained an SMP domain
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Fig. 2. PDZD8 is required for the formation of the ER-mitochondria contacts in mammalian
cells. (A to D) The 3D ultrastructural features of control HeLa cells or PDZD8-KO HeLa cells (24)
were examined with FIB-SEM. [(A) and (B)] Representative individual electron micrographs of
control (A and A′) or PDZD8-KO (B and B′) cells. The mitochondria and ER were labeled with green
and magenta, respectively (A′ and B′). The ER-mitochondria contact sites are indicated by dashed
white lines (<25 nm distance between membranes). [(C) and (D)] The 3D distribution of single
continuous mitochondria (green) and corresponding ER-mitochondria contact sites (magenta)
reconstructed from FIB-SEM image stacks of a control (A) and a PDZD8-KO HeLa cell (B).
(E to J) Quantification of the ER-mitochondria contact sites [(E) to (G)], mitochondrial (H), and
ER [(I) and (J)] morphology from the 3D reconstructions. (E) Percentage of mitochondrial surface
area in direct contact with ER is significantly decreased in PDZD8-KO HeLa cells compared with
control HeLa cells (see also movies S2 to S5). (F) Percentage of ER surface area in contact with
mitochondria is also significantly reduced in PDZD8-KO HeLa cells compared with control HeLa cells.
(G) Average surface area of ER-mitochondria contact sites in PDZD8-KO HeLa cells is significantly
decreased compared with control cells. [(H) and (I)] Mitochondrial (H) or ER (I) surface area to
volume ratio is not significantly different between control and PDZD8-KO HeLa cells, suggesting the
absence of significant change in the overall structure of both organelles. (J) Quantification of the
number of three-way junctions in the ER network, a quantitative index of the extent of tubular ER
(25, 26). The number of three-way junctions in the ER structure is not significantly different in
PDZD8-KO HeLa cells compared with control cells. [(E), (G), and (H)] The total number of the
contact sites identified in these serial EM reconstructions was 2011 (control) and 3197 (PDZD8-KO)
from 10 control and 11 PDZD8-KO mitochondria fully reconstructed. For (F), (I), and (J), the ER
network was quantified in regions surrounding mitochondria in four to six cells of each genotype. A
nonparametric Mann-Whitney test was used to test statistical significance. **P < 0.01; ****P <
0.0001. Cells quantified are from two independent cell cultures. Data are displayed as mean ±
standard error of the mean. n.s., not significant.













structurally and functionally orthologous to yeast
ERMES complex proteinMmm1, we investigated
whether PDZD8 functioned as a tethering pro-
tein and whether it was required for the for-
mation of ER-mitochondria contacts. To map
ER-mitochondria contacts quantitatively, we
performed three-dimensional serial scanning
electron microscopy (3D SEM) using focus ion
beam–scanning EM (FIB-SEM) (Fig. 2 and movies
S2 to S5). The 3D reconstructions of FIB-SEM
stacks showed that the volume-surface ratio of
mitochondria (Fig. 2H) and ER (Fig. 2I) and the
number of three-way junctions (an index often
used to measure ER tubule complexity (25, 26)
(Fig. 2J) were not significantly different between
the control and PDZD8 knockout (KO) cells
(24). Thus, deletion of PDZD8 had no detectable
effect on the structure of mitochondria and ER
networks (Fig. 2, H to J, and movies S2 to S5).
We also quantified the size and distribution
of ER-mitochondria contact sites [defined as
membrane appositions between the two organ-
elles with less than 25 nm distance (16)] on 10
mitochondrial segments from five HeLa cells
(total surface area 2.8 × 102 mm2; total volume
13 mm3) and 11 mitochondrial segments from
six PDZD8 KO HeLa cells (total surface area
3.0 × 102 mm2; total volume 17 mm3). As previously
reported (2, 27, 28), 11.2% of the mitochondrial
surface area was in contact with ER in control
HeLa cells but, strikingly, only 2.2% of mito-
chondrial surface was in contact with ER in
PDZD8 KO cells (Fig. 2E). We also normalized
the surface of ER-mitochondria contacts relative
to ER surface area: 16.5% of the ER surface area
was in contact with the mitochondria in control
cells, but only 2.1% of ER surface was in contact
with the mitochondria in PDZD8 KO cells (Fig.
2F). Furthermore, the average surface of indi-
vidual ER-mitochondria contacts was also de-
creased by ~80% in PDZD8 KO HeLa compared
with control HeLa cells (Fig. 2G). These results
strongly suggested that PDZD8 is required for
tethering ER and mitochondria membranes in
human cells.
PDZD8-mediated tethering is critical for
ER-mitochondria Ca2+ transfer
ER-mitochondria contacts are emerging as sig-
naling hubs and have been proposed to play a
critical role in Ca2+ exchange between these two
organelles (2, 28–30). Upon activation of ryan-
odine and/or inositol-1,4,5-trisphosphate (IP3)
receptors (IP3R), Ca
2+ released from the ER tran-
siently reaches concentrations high enough to
open the mitochondrial calcium uniporter (MCU)
complex at the ER-mitochondria contacts (30–32),
promoting efficient mitochondrial Ca2+ uptake.
To determine whether ER-mitochondria tethering
by PDZD8 plays a role in Ca2+ transfer between
these two organelles, we monitored Ca2+ dynam-
ics in the ER and mitochondria simultaneously
(33). We expressed genetically encoded Ca2+ in-
dicators (GECI) targeted to the ER (red fluores-
cence; R-CEPIA1er) (33) and the mitochondria
(green fluorescence; CEPIA3mt) (33). In control
NIH3T3 cells, stimulation of purinergic recep-
tors with extracellular adenosine 5′-triphosphate
(ATP) (34), which generates IP3, robustly acti-
vates IP3R and induced Ca
2+ release from ER stores
leading to rapid Ca2+ import into mitochondria
(Fig. 3 and movie S6). In contrast, in NIH3T3
cells expressing short hairpin RNA (shRNA) ef-
ficiently knocking down Pdzd8 (fig. S6, B and C,
and fig. S7, B and C), Ca2+ import into mitochon-
dria after ATP stimulation was significantly re-
duced, even though Ca2+ release from the ER was
not significantly affected (Fig. 3; movie S7; and
fig. S8, C and D). In addition, expression of an
shRNA-resistant Pdzd8 cDNA restored Ca2+ up-
take into mitochondria in ATP-treated NIH3T3
cells expressing Pdzd8 shRNA (Fig. 3). Importantly,
resting Ca2+ levels in both ER and mitochondria
(fig. S8, E and F), ER-independent mitochondrial
Ca2+ import (fig. S9, A and B), and mitochondrial
membrane potential (fig. S9, C and D) were not
significantly altered in PDZD8-deficient cells. Fur-
thermore, expression levels of mitochondrial Ca2+
regulatory proteins and other tethering proteins
were not altered in Pdzd8 knockdown NIH3T3
cells (fig. S9, E to H).
To determine whether this reducedmitochon-
drial Ca2+ import in Pdzd8-deficient cells was
indeed due to the loss of the ER-mitochondria
contacts, we performed a rescue experiment using
a synthetic tethering protein (28) that restored
ER-mitochondria contacts (fig. S8A). Expression
of a synthetic ER-mitochondria tethering con-
struct almost completely rescued themitochondrial
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Fig. 3. PDZD8-dependent membrane contacts are required for ER-mitochondria Ca2+ transfer.
NIH3T3 cells were transfected with plasmids encoding mitochondria-targeted GECI (CEPIA3mt),
ER-targeted GECI (R-CEPIA1er), and combinations of constructs indicated [a control plasmid
(Control), a Pdzd8 shRNA plasmid, a Pdzd8 shRNA-resistant Pdzd8 cDNA-expressing plasmid,
or a synthetic ER-mitochondria tethering protein]. Cells were stimulated with 200 mM extracellular
ATP, and fluorescence from CEPIA3mt and R-CEPIA1er was measured. (A to D) Changes of
fluorescence (DF) from R-CEPIA1er [(A) and (B)] or CEPIA3mt [(C) and (D)], normalized by basal
signals before the stimulation (F0). Peak intensity of DF/F0 at 10 s after ATP stimulation shows
significant reduction of mitochondrial Ca2+ uptake [(C) and (D)], but not ER Ca2+ release [(A)
and (B)], in Pdzd8-depleted cells (red lines and bars) compared with those in the control (black
lines and bars). This altered phenotype is rescued by introducing a shRNA-resistant Pdzd8
plasmid (green lines and bars) or a synthetic ER-mitochondria tethering protein (blue lines and
bars). n = 67 for control, 71 for Pdzd8-KD, 32 for Pdzd8 rescue, and 30 for tethering. Statistical
significance: n.s., P > 0.05; *P < 0.05; **P < 0.01; ****P < 0.0001, according to unpaired t test with
Welch’s correction.
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Fig. 4. PDZD8 loss of function in cortical neurons identifies a novel
role for ER-mitochondria interface in the regulation of cytoplasmic
Ca2+ dynamics in dendrites. (A to F) Dendritic ER and mitochondrial
Ca2+ dynamics were monitored using G-CEPIA1er and mito-RCaMP1h,
respectively. G-CEPIA1er and mito-RCaMP1h were cotransfected
with control or Pdzd8 shRNA plasmids using ex utero electroporation
at embryonic day 15.5 and imaged at 19 to 22 days in vitro (DIV).
Proximal dendrites of cortical pyramidal neurons display significant
ER Ca2+ release and mitochondrial Ca2+ uptake after physiological
stimulation of presynaptic release (20 AP at 10 Hz). Representative
images are displayed as normalized ratio (DF/F0) of each probe [(A)
and (B)]. This stimulation evokes normal ER Ca2+ release in dendrites
of both control and PDZD8-deficient neurons [(C) and (D)] but shows
significantly decreased mitochondrial Ca2+ import [(E) and (F)]. n = 63
dendritic segments from 18 neurons for control and 28 dendritic
segments from 14 neurons for Pdzd8 knockdown. (G to L) Dendritic ER
(G-CEPIA1er) and cytosolic Ca2+ (RCaMP1h) levels were visualized
before and after 20 AP in 21 to 22 DIV cortical neurons. [(G) and (H)]
Cropped images show fluorescence as ratio normalized by basal
signals before stimulation (DF/F0). Cytosolic Ca
2+ accumulation is
significantly higher in Pdzd8 knockdown neurons compared with
control [(K) and (L)] despite unchanged ER Ca2+ release evoked by
synaptic stimulation [(I) to (J)]. n = 30 dendritic segments from
10 neurons for control and 39 dendritic segments from 13 neurons for
Pdzd8 knockdown. Statistical significance: n.s., P > 0.05; **P < 0.01;
***P < 0.001, according to unpaired t test with Welch’s correction.













Ca2+ uptake induced byATP application in PDZD8-
deficient cells back to control levels (Fig. 3). Thus,
our results demonstrate that ER-mitochondria
tethering mediated by PDZD8 is required for
efficient Ca2+ transfer from ER into mitochondria
in metazoan cells.
Synaptically induced Ca2+ release from ER
stores triggers mitochondrial Ca2+ uptake
Cytoplasmic Ca2+ dynamics in dendrites of
neurons are critical for physiological responses,
including synaptic integration and plasticity
(35, 36). Although several studies have suggested
that ER stores and mitochondria can influence
dendritic Ca2+ dynamics (37–47), the functional
importance of ER-mitochondria contacts is un-
known in neurons. PDZD8was expressed at high
levels throughout the developing and adult mouse
central nervous system (CNS), including in the
neocortex (fig. S10). Thus, we investigated whether
ER-mitochondria tethering by PDZD8 affected
Ca2+ dynamics in dendrites of mouse cortical
pyramidal neurons.
We used green (G)–CEPIA1er and mitochondria-
targeted RCaMP1h (mito-RCaMP1h) to visualize
ER ([Ca2+]ER) and mitochondrial matrix Ca
2+
([Ca2+]mito) dynamics simultaneously (33, 48) in
synaptically mature cortical pyramidal neurons.
We induced synaptic activity by stimulation with
a concentric bipolar electrode [20 action poten-
tials (AP) at 10Hz], which efficiently triggers pre-
synaptic release in close proximity to the dendrites
of target neurons (49). The dendrites of untreated,
control cortical pyramidal neurons showed robust
ER Ca2+ release and mitochondrial Ca2+ uptake
after synaptic stimulation (fig. S12). Mitochon-
drial Ca2+ import in dendrites was dependent on
ER Ca2+ release by applying a sarco/endoplasmic
reticulumCa2+-ATPase (SERCA) inhibitor as shown
by application of cyclopiazonic acid (CPA). CPA
treatment efficiently depleted [Ca2+]ER and also
abolished mitochondrial Ca2+ uptake (fig. S12, A
to F). Thus, Ca2+ released from ER stores is the
main source of mitochondrial Ca2+ import in
dendrites of cortical pyramidal neurons. Pre-
vious studies have suggested that activation of
postsynaptic N-methyl-D-aspartate (NMDA) re-
ceptors and/or metabotropic glutamate recep-
tors (mGluR) trigger efficient Ca2+ release from
ER stores (40, 41, 44–46, 50). Consistent with
this, incubation with the NMDA receptor antag-
onist D-2-amino-5-phosphonovaleric acid or the
mGluR1 blocker LY367385 abolished ER Ca2+
release and suppressed mitochondrial Ca2+ im-
port (fig. S12, G to N). Thus, as expected, activation
of both NMDA receptor and mGluR1 are re-
quired for synaptically evoked Ca2+ release from
ER stores in the dendrites of cortical pyramidal
neurons (Fig. 5A).
PDZD8 regulates dendritic Ca2+
dynamics in cortical neurons
Pdzd8 knockdown in cortical layer II/III pyram-
idal neurons did not impair the overall structure
anddistributionof dendriticERandmitochondria
in vivo (fig. S11). To determine whether PDZD8-
dependent ER-mitochondria membrane tether-
ing regulatesERandmitochondrial Ca2+dynamics
in neuronal dendrites, we introduced G-CEPIA1er
and mito-RCaMP1h with either control or Pdzd8
shRNA using ex utero electroporation in cortical
pyramidal neurons. After physiological synaptic
stimulation (20 AP at 10 Hz), Ca2+ release from
ER stores was coupled with robust mitochondrial
Ca2+ import in dendrites expressing control shRNA
(Fig. 4, A to F, and movie S8). However, mitochon-
drial Ca2+ import was significantly reduced in
Pdzd8 knockdown neurons, consistent with data
obtained inNIH3T3 cells (Fig. 4, B, E, and F, and
movie S9). Expression levels of MCU or proteins
proposed to regulate ER-mitochondria contacts
(PIPIP51 and VDAC1) were not changed in Pdzd8
knockdown neurons (fig. S13, A to D). Further-
more, mitochondrial Ca2+ import and extrusion
kinetics, as well as resting Ca2+ amount in ER
and mitochondria, were not altered in PDZD8-
deficient neurons (fig. S13, E to J). These results
strongly suggest that the significant reduction of
mitochondrial Ca2+ import upon induction of ER
Ca2+ release in dendrite PDZD8-deficient neurons
is most likely due to the loss of ER-mitochondria
contacts rather than to secondary effects due
to alteration of the mitochondrial Ca2+ import
machinery.
Finally, we investigated whether this uncou-
pling of ER-mitochondria Ca2+ exchange by PDZD8
loss of function resulted in impaired cytosolic Ca2+
([Ca2+]c) dynamics. To do this,we coelectroporated
G-CEPIA1er and cytosolic RCaMP1h together with
control or Pdzd8 shRNA and imaged them before
and after synaptic stimulation (20 AP at 10 Hz).
[Ca2+]c levels were significantly elevated in Pdzd8
knockdown dendrites comparedwith control den-
drites (Fig. 4, G to L). Thus, a significant fraction of
Ca2+ released from ER stores is directly imported
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Fig. 5. PDZD8 is an ER-mitochondria tethering protein regulating dendritic Ca2+ dynamics in
neurons. Schema summarizing the main findings in this study. (A) In dendrites of cortical pyramidal
neurons, synaptically induced ER Ca2+ release requires both mGluR and NMDA receptor (see
results in fig. S12). Our results demonstrate that the majority of synaptically induced Ca2+ imported
into dendritic mitochondria originates from ER stores. (B and C) Our results also demonstrate
that in neuronal dendrites, PDZD8-dependent ER-mitochondria tethering plays a critical role in
cytoplasmic Ca2+ homeostasis because in the absence of PDZD8 (C), a significantly higher fraction
of synaptically induced Ca2+ release from the ER ends up in the cytoplasm rather than in the
mitochondrial matrix, compared with control (B).













into mitochondria upon synaptic activation in
control dendrites, and PDZD8 regulates cyto-
plasmic Ca2+ dynamics in dendrites through its
function in ER-mitochondria tethering.
Here, we have identified PDZD8 as an ER-
mitochondria tethering protein in metazoan
cells and demonstrated that the SMP domain–
containing protein PDZD8 might represent a
structural and functional ortholog of the yeast
ERMESprotein componentMmm1. Furthermore,
our results also demonstrate the importance of
ER-mitochondria tethering for dendritic Ca2+
homeostasis in mammalian neurons (Fig. 5, B
and C). Dendritic Ca2+ dynamics play several
critical functions ranging from synaptic integra-
tion properties to various forms of synaptic plas-
ticity (35, 36). Cytoplasmic Ca2+microdomains in
neuronal dendrites represent a cellular mech-
anism recently proposed to regulate branch-
specific synaptic integration and plasticity (51, 52).
We suggest that the control of cytoplasmic Ca2+
dynamics in dendrites involves ER-mitochondria
coupling and, by analogy to its proposed functions
in non-neuronal cells, this organelle interface
might play other important biological functions
such as lipid exchange and coupling of mitochon-
drial DNA replication with mitochondrial fission
in neurons.
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Material and Methods 
Animals 
All animals were housed and handled according to protocols approved by the Institutional 
Animal Care and Use Committee (IACUC) at Columbia University. Time-pregnant CD1 
females were purchased from Charles River (Wilmington MA, USA).   
 
Constructs 
pCAG::mito (CoxVIII)-mTAGBFP2 was previously described (53). C-terminal HA-
tagged mouse PDZD8 was cloned with from cDNA library obtained from C57/Bl6 mouse 
brain by PCR. pCAG PDZD8HA was created by inserting the mouse PDZD8 coding 
sequence at XhoI-NotI sites of pCIG2 vector. pCAG PDZD8HA resistant to shPDZD8 
was created by primers having silent mutations at the shPDZD8 targeting site. pLKO1.5 
shPDZD8 (TRCN0000431056) was from Sigma Aldrich. Control vector used in shRNA 
experiments is the pLKO1 vector from TRC library (expressing small RNA sequence 
CCGCAGGTATGCACGCGT). pCAG::Calnexin-YFP was created by replacing 
mitochondria targeting sequence of pCAG::mito-YFP (53) with Calnexin coding 
sequence. pCAG::Calnexin-mCherry was created by replacing YFP sequence with 
mCherry sequence. Synthetic ER-mitochondria tethering construct was created by 
replacing mitochondria targeting sequence of pCAG-mito-mtagBFP2 (53) with DNA 
oligomers coding a mitochondria targeting sequence (AKAP) and inserting DNA 
oligomers coding ER targeting sequence (UBC6) at the 3’ end of mtagBFP2 at the BsrGI 
site (28). pCMV::CEPIA3mt, pCMV::R-CEPIA1er, and pCMV::G-CEPIA1er were gifts 
from Masamitsu Iino (Addgene plasmid # 58219, 58216, 58215, respectively). For 
cytosolic RCaMP1h, we inserted RCaMP1h from pRSET-RCaMP1h (Addgene plasmid 
#42874) to pCIG2 by replacing IRES-GFP. pCAG::mito-RCaMPh1 was generated by 
swapping GCaMP5G with RCaMP1h in pCAG::mito-GCaMP5G (54). pCAG::G-
CEPIA1er and pCAG::CEPIA3mt were created by inserting G-CEPIA1er and CEPIA3mt 
into pCAG vector, respectively. 
 
Generation of Pdzd8-Venus knock-in Neuro2a cell line 
For CRISPR-Cas9 plasmid, CRISPR guide RNA was designed using Optimized CRISPR 
Design tool (http://crispr.mit.edu) and cloned into pSpCas9(BB)-2A-Puro (PX459) V2.0 
(a gift from Feng Zhang; Addgene plasmid # 62988) as previously described (55). For the 
donor vector, 5’ arm sequence was amplified from pCAG-PDZD8HA with primers 
containing silent mutations at the CRISPR target site. 3’UTR sequence was cloned from a 
bacterial artificial chromosome (RP23-373G10, BACPAC resources). These sequences, 
together with Venus, P2A, and Neo sequences, were cloned into the XhoI-NotI restriction 
enzyme sites of pCIG2 with In-Fusion HD cloning kit (Takara Bio). Neuro2a cells were 
transfected with CRISPR-Cas9 plasmid and the donor vector by Jetprime (Polyplus-
transfection). Cells were replated after 24 hours and treated with puromycin (2µg/ml) to 
select transfected cells for 2 days. The selected cells were then cultured with Geneticin 
(G418 sulfate, 400 µg/ml; Sigma-Aldrich A-1720) to select successfully recombined 
cells. 
 
Super-resolution imaging (3D-SIM) 
Neuro2a-PDZD8-Venus-KI cells were plated on a High-performance cover glass (D = 
0.17, Carl Zeiss Microscopy) and transfected with pCAG Canx-mCherry by Jetprime and 
cultured for two days. Transfected cells were fixed with 4% PFA for 10’ followed by 
fixation with ice cold methanol for 6min. Cells were then treated with 3% BSA/PBS for 
30’ followed by an incubation with primary antibodies against GFP (1:2000, GFP-1020; 
Aves labs), RFP (1:1000, ab62341; Abcam), and anti-OxPhos Complex (1:500, Thermo 
Fisher Scientific) overnight at 4ºC. After treated with secondary antibodies anti-mouse 
IgG Alexa 405, anti-chicken IgG Alexa 488, and anti-rabbit IgG Alexa 546 (Thermo 
Fisher Scientific), the coverslip was mounted on a slide glass with ProLong® Diamond 
Antifade Mountant (Thermo Fisher Scientific). Cells were imaged with Nikon Ti Eclipse 
inverted microscope equipped with a SIM illuminator, an iXon Ultra 897 camera 
(Andor), and a × 100 plan apochromat immersion oil objective (NA 1.49). Image 
reconstruction and analysis were performed with the NIS-Elements software (Nikon). 
 
Cell Culture 
Neuro2a (ATCC), HeLa cells (ATCC), PDZD8 KO HeLa cells (gift from Dr. Joseph 
Sodroski) and NIH3T3 cells (ATCC) were maintained with Dulbecco's Modified Eagle 
Medium (Thermo Fisher Scientific) supplemented with 10% FBS (Gemini Bio-products) 
and 1% Penicillin-Streptomycin (Thermo Fisher Scientific) under 5% CO2. 
 
Neuronal Culture 
Embyonic mouse cortices (E15.5) were ex utero electroporated following the injection of 
plasmids to ventricles, then dissected in Hank’s Buffered Salt Solution (HBSS) 
supplemented with HEPES (10mM, pH7.4). Tissues were incubated in HBSS containing 
papain (Worthington; 14U/ml) and DNase I (100 μg/ml) for 15min at 37°C. Then, 
samples were washed 3 times with HBSS containing DNase I, and dissociated by gentle 
pipetting. Dissociated cells (8.5x104) were plated on poly-D-lysine (1mg/ml, Sigma)-
coated glass bottom dishes (MatTek, 35mm dishes with 14mm glass diameter) in 
Neurobasal media (Invitrogen) containing B27 (1x), Glutamax (1x), FBS (2.5%) and 
penicillin/streptomycin (0.5x) (all supplements were from Invitrogen). After 5 to 7 days, 
media were changed with FBS-free supplemented Neurobasal medium. 
 
 
Structural modeling  
Structural homology search for, and corresponding structural homology modeling based 
on PDB structures mapping to PDZD8 and Mmm1 was performed through the Phyre2 
web portal (56). Structural analysis, tertiary alignments and visualizations of the E-syt2 
(4P42) and Mdm12 (5gyk) PDB structures and SMP-domain homology models generated 
for PDZD8 and Mmm1 was carried out with PyMOL Molecular Graphics System 
(Version 1.8 Schrödinger, LLC).  
 
Yeast strain construction 
S. cerevisiae strains for mmm1Δ-rescue experiments were derived from the heterozygous 
mmm1Δ/MMM1 diploid strain YLL006W (BY4743; MATα/α, his3Δ1/his3Δ1, 
leu2Δ0/leu2Δ0, LYS2/lys2Δ0, met15Δ0/MET15, ura3Δ0/ura3Δ0) from the Yeast 
Knockout Collection (GE Healthcare Dharmacon Inc.). All other strains were derived 
from from wild-type BY4741 (MATa his3Δ0, leu2Δ0, met15Δ0 and ura3Δ0) from Open 
Biosystems (Huntsville, AL). C-terminal tagging of yeast endogenous proteins with 
fluorescent proteins was performed through homologous recombination as previously 
described (57). Briefly, PCR-fragments with 40bp-flanking regions homologous to 40bp 
upstream and downstream of pertinent stop-codons, containing mCherry or mTFP1 ORFs 
followed by suitable selectable markers were generated from plasmids pCY3080-07 
(Addgene) and pFA6:mTFP1:kanMX (available upon request). Transformations were 
performed using the lithium acetate method (ref). Transformants were selected on 
suitable auxotrophic medium or medium containing 300 µg ml−1 Hygromycin B (for 
hphMX4) (Life Technologies, Carlsbad, CA).  
 
Sporulation and tetrad dissection to derive haploid strains from 
mmm1Δ:KanMX6/MMM1, CIT1-mCherry: hphMX4/CIT1 diploid strains containing 
pRESC with a pertinent test-construct was carried out according to previously published 
protocols (58). Briefly, cells were incubated in sporulation medium (SPO) on a rotating 
wheel for 7 days. Asci were digested in 1M sorbitol with 2.5mg/ml zymolase (Seikagaku 
Corp., Tokyo Japan) for 7 min and tetrad dissection was carried out on SE -URA dropout 
plates containing 200 µg ml−1 Geneticin (for KanMX6) (Sigma-Aldrich) or 
300 µg ml−1 Hygromycin B (for hphMX4). Haploid status and correct segregation of 
genomic alleles and plasmids was confirmed by PCR. Plasmids were cured on 5-FOA 
plates (SC supplemented with 50 µg ml−1 Uracil and 1% 5-Fluoroorotic acid (5-FOA; 
Sigma-Aldrich, St Louis, MO)). Single colonies were picked and grown in 5-FOA liquid 
medium.  
 
Yeast growth conditions 
Yeast strains were grown and handled as previously described (59). All cells were grown 
at 30 °C (shaking for liquid cultures) in synthetic complete (SC) medium, unless 
otherwise stated. For strains requiring selection, appropriate SC dropout medium was 
used. All imaging was carried out during logarithmic phase.  
 
pRESC construction 
pRESC was derived from p416TEF (ATCC® 87368™) by replacing the TEF-promoter 
with 1000bp directly upstream of the MMM1-ORF. Rescue inserts were derived by PCR 
or synthesized by GENEWIZ® (South Plainfield, NJ).  
 
Staining of mitochondrial DNA using DAPI 
mtDNA was visualized by DAPI staining in live cells in SC containing 1 μg/ml DAPI. 
Cells were stained for 10 min shaking at room temperature, washed three times, and 
imaged immediately. 
 
Yeast microscopy and image analysis 
Fluorescent microscopy was carried out one of the following microscopes: an Axioskop 2 
microscope with 100x/1.4 Plan-Apochromat objective (Zeiss, Thornwood, NY) and an 
Orca ER cooled CCD camera (Hamamatsu) or an inverted AxioObserver.Z1 microscope 
with a 100x/1.3 oil EC Plan-Neofluar objective (Zeiss, Thornwood, NY) and Orca ER 
cooled CCD camera (Hamamatsu, Bridgewater, NJ). Images were collected through the 
entire cell depth (21 z-sections at 0.3-μm intervals) and deconvolved using an iterative 
restoration algorithm (Volocity, Perkin-Elmer, Waltham, MA). Budding cells stained 
with DAPI were scored for presence of mitochondrial DNA that co-localizes with 
mitochondria in 3-dimensional reconstructions. To avoid errors due to incidental co-
localization of mitochondria with nuclei in dividing cells, cells with less than three 
individual DAPI foci co-localizing with mitochondria were scored as rho0. Mitochondrial 
inheritance dynamics was analyzed in budding cells expressing Cit1p-mCherry with 
daughter-cell diameters smaller than two-third of the mother-cell (small-to-medium 
buds). Mitochondrial morphology was analyzed by classifying mitochondrial objects in 
three categories based on geometric parameters. To this end, mitochondrial objects were 
detected, and mitochondrial volumes and skeletons were derived in Volocity using inbuilt 
algorithms. The tubularity of mitochondrial objects was determined by calculating the 
tubular radius (d) of an ideal cylinder (Fig. S5A) based on the determined volume (V) 
and skeletal length (h) as: 
 𝑉𝜋ℎ = 𝑟 
 
 
Mitochondrial objects were defined as tubular if the skeletal length ℎ ≥ 2.5𝑟 and 
spherical if ℎ < 2.5𝑟 (Fig. S5A-C). As this simple classifier fails for very small objects 
(Fig. S5C), mitochondria were categorized as fragmented regardless of tubularity, if their 
skeletal length was less than 0.325µm. During normal mitochondrial inheritance in WT 
cells, mitochondria accumulate at the daughter-cell tip and form aggregates that would be 
classified as spherical (Fig. S5D). To avoid this confounding factor, mitochondrial 
morphology was analyzed in mother cells only.  
 
Western blotting 
Cells were lysed with RIPA buffer (50mM Tris-HCl pH7.2, 500mM NaCl, 1% Triton X-
100, 0.5% Sodium deoxycholate, 0.1% SDS, 10mM MgCl2) supplemented with the 
cocktail of protease inhibitors (Roche), and Benzonase (EMD Millipore) at 37°C for 
30min. Samples were loaded onto SDS-PAGE gels and transferred to polyvinylidene 
difluoride (PVDF) membrane (Amersham). After transfer, membranes were blocked for 1 
h with blocking buffer (Li-Cor technology), followed by incubation with primary 
antibodies overnight at 4°C. The membranes were washed four times with 0.1% 
TritonX100/PBS and incubated with fluorescent secondary antibodies (Li-Cor 
technology) for 1 h at room temperature, followed by four times washes with 0.1% 
TritonX100/PBS. The membranes were scanned by Odyssey® CLx Imaging System (Li-
Cor technology). Primary antibodies are rabbit anti-PDZD8 (1:500, in Fig. 1E and Fig. 
S7A) (24) , rabbit antiserum against a peptide corresponding to a.a. 1103-1119 of mouse 
PDZD8 (DQHSKKMNKYADDTEED) raised by Covance (1:500, in Fig. 6B), chicken 
anti-GFP (1:2000, GFP-1020; Aves labs), mouse anti-HA (1:2000, clone 16B12, 
BioLegend), mouse anti-actin (1:5000, Millipore), rabbit anti-VDAC1 (1:500, #4866, 
Cell Signaling Technology), rabbit anti-MCU (1:500, HPA016480, Sigma Aldrich), and 




Cortical neuron culture was infected with lentivirus carrying either the control or 
shPDZD8 at 4 DIV. RNA was isolated at 13DIV with NucleoSpin® RNA 
(MACHEREY-NAGEL) according to the instructions of the manufacturer. cDNA was 
reverse transcribed using SuperScript® III First-Strand Synthesis SuperMix for qRT-
PCR (Life Technologies) according to the directions of the manufacturer. The resulting 
cDNA was analyzed using quantitative PCR with Power SYBR® Green PCR Master Mix 
(Life Technologies) in an Eppendorf Realplex using the following primers:  
Actin 
5’- GGCTGTATTCCCCTCCATCG -3’ 
5’- CCAGTTGGTAACAATGCCATGT-3’ 
Mouse PDZD8 
5’- TTGACATAGAAGCCTGCCATAG -3’ 




Isolation of ER, mitochondria, and MAM from HEK293T cells and PDZD8-Venus 
knock-in Neuro2a cells was performed following the previously described protocols (3, 
60, 61). HEK293T cells or Neuro2a cells were harvested from 50 dishes (10cm) at 90-
100% confluence and homogenized in isolation buffer (225mM mannitol, 75mM sucrose, 
0.1mM EGTA, 30mM Tris-HCl pH7.4) using a Teflon pestle until 80-90% of cells were 
broken. Then, the homogenate was centrifuged at 600g for 10min twice for removing 
nuclei and debris. Collected supernatant was centrifuged for 15min at 7000g for 
obtaining crude mitochondria. For ER isolation, this step was repeated with the 
supernatant until a pellet is no longer visible, and the supernatant was centrifuged at 
20,000g for 30min. Then, the mitochondria-free supernatant was centrifuged again at 
100,000g for 1h and the pellet was resuspended for the ER fraction and the supernatant 
was kept for the cytosolic fraction. For pure mitochondria and MAM fraction, the crude 
mitochondria pellet was resuspended in 4x-5x volume resuspension buffer (250mM 
mannitol, 5mM HEPES pH7.4, 0.5mM EGTA), and the fraction was added on the top of 
30% percoll medium (225mM mannitol, 25mM HEPES pH7.4, 1mM EGTA, 30% 
percoll (v/v)) in a centrifuge tube. Centrifuge was performed at 95,000g for 30min, and 
then the upper (MAM) and lower layer (pure mitochondria) were collected with a Pasteur 
pipette. Both fractions were diluted with 10x volume resuspension buffer and centrifuged 
at 6,300g for 15min. Then, the pure mitochondria fraction was obtained from the pellet 
after one more wash with the same condition. The supernatant containing the MAM was 
centrifuged at 100,000g for 1h and the resulting pellet was resuspended in resuspension 
buffer. Western blot was performed using chicken anti-GFP (1:2000, GFP-1020; Aves 
labs), rabbit anti-PDZD8 (1:500), mouse anti-Calnexin (1:500, 610523; BD bioscience), 
and mouse anti-cytochrome C (1:1000, 556433; BD bioscience) antibodies. 
 
Confocal imaging 
Samples were imaged with either a 20x (0.75 NA) air objective or 60x (1.4 NA) oil 
objective on a Nikon Ti-e inverted microscope equipped with a Nikon A1 confocal. 
 
Immunohistochemistry 
Following anesthesia, mice were heart perfused with 5ml of phosphate buffered saline 
(PBS 0.1M) and subsequently with 40ml of the fixative solution containing 2% 
paraformaldehyde (EM grade, EMS) and 0.025% of Glutaraldehyde (GA, EMS) diluted 
in PB. Brains were then dissected out and post-fixed in the same fixative solution for 3 
hours. After embedded in low melting agarose (3%, MP Biomedicals), brains were 
sectioned at 100µm thickness with a Leica VT1200S vibratome. Sections were treated 
with ice cold methanol for 6’ and blocked with 2% goat serum/PBS for 30 min followed 
by incubation with anti-GFP at 4ºC overnight. Sections were then washed with PBS 




HeLa cells and PDZD8 KO HeLa cells were fixed with 2% glutaraldehyde (EMS) in 
0.1M Phosphate buffer, pH7.4 for 1h at room temperature. After washing with 0.1M 
Phosphate buffer, cells were scraped and collected with 0.2% BSA/0.1M phosphate 
buffer followed by centrifugation at 3000 rpm. The samples were post-fixed with 1% 
OsO4, 1.5% potassium ferricyanide in 0.1M Phosphate buffer for 1 hour. After 3 times 
rinse with distilled water, cells were stained with 10% thiocarbohydrazide for 5min 
followed by incubation with 1% aqueous uranyl acetate for 30 min at room temperature. 
The samples were rinsed in water, dehydrated in an ethanol series and then infiltrated and 
embedded in Epon resin (62).  
The sample block was trimmed then mounted on a SEM sample holder using double-
sided carbon tape (EMS). Colloidal silver paint (EMS) was used to electrically ground 
the exposed edges of the tissue block. The entire surface of the specimen was then sputter 
coated with a thin layer of gold/palladium. The tissue was imaged using back scattered 
electron (BSE) mode in a FEI Helios Nanolab 650. Images were recorded after each 
round of ion beam milling using the SEM beam at 2keV and 100pA with a working 
distance of 4.0 mm. Data acquisition occurred in an automated way using the Auto Slice 
and View G3 software. The raw images were 2,048x1,768 pixels, with 20 nm slices 
viewed at a -38 degree cross-sectional angle. Each raw image had a horizontal field width 
(HFW) of 15 µm with an XY pixel size of 7-9 nm and 20 nm Z slices. These images were 
then aligned using the image processing programs in IMOD (63).  
 
Analysis of 3D-SEM imaging 
3D-SEM images were manually segmented with a Fiji plug-in Track-EM2. Segmented 
images were imported to Imaris (Bitplane) and analyzed with Surface-Surface contact 
plug-in. In Imaris, surface-area and volume were calculated using the Statistics feature. 
The area of ER analyzed was chosen based on localization in region containing the 
mitochondrial network which was also reconstructed systematically. 
 
ER Three-way Junction Quantification 
Three-way junctions in the 3D-SEM images of ER were quantified using a Fiji plug-in 
Track-EM2. Three-way junctions were identified at points where three distinct ER 
segments branched from. Quantification of three-way junctions was normalized by the 
surface area of the ER that was analyzed. The area of ER analyzed was chosen based on 
localization to the mitochondrial network.  
 
Calcium imaging 
NIH3T3 cells were plated and transfected with plasmids with Jetprime or FugeneHD 
(Promega). Cells were replated on glass bottom dishes (MatTek) at 1x104/cm2 density and 
incubated for 1 day. The medium was replaced with Hank’s buffered salt solution 
(HBSS) supplemented with HEPES (pH7.4; 2.5mM), CaCl2 (2mM, Sigma), MgSO4 
(1mM, Sigma), NaHCO3 (4mM, Sigma), and D-glucose (30mM, Sigma). Cells were 
stimulated with 200µM ATP (Sigma Aldrich, A1852) and imaged with an inverted Nikon 
Ti-E microscope equipped with EMCCD camera (Andor, iXon3-897), 20x objective 
(0.75NA). 470nm, 555nm, and 360nm Spectra X LED lights (Lumencor) were used for 
the light source, and a custom quad-band excitation/mirror/emission cube (based off 
Chroma, 89400) followed by clean up filters (Chroma, ET525/50, ET600/50, ET435/26) 
were applied for excitation and emission.  
For experiment with permeabilized cells (Fig. S9), cells were treated with 2.5µM 
digitonin (Sigma-Aldrich) and 20µM cyclopiazonic acid (CPA; Tocris) in intracellular 
buffer (130mM KCl, 10mM NaCl, 2mM K2HPO4, 5mM succinic acid, 1mM MgCl2, 
20mM HEPES) for 3min before imaging. After 10s of imaging, cells were stimulated by 
application of a solution containing 1mM CaCl2 and imaged for another 20s. To confirm 
the Ca2+ uptake is mediated by MCU, cells were treated with MCU inhibitor 10µM 
RU360 (Calbiochem).  
For neuronal calcium imaging, electroporated cortical neurons were imaged using the 
same microscope (40x objective NA 0.95) with an EMCCD (Andor, iXon3-897) camera 
at 19-22DIV. 470nm and 555nm LED lights were applied for the light source, and the 
same cube and clean up filters (Chroma, ET525/50, ET600/50) were used for dual color 
imaging. We imaged neurons in modified normal tyrode solution (145mM NaCl, 2.5mM 
KCl, 10mM HEPES pH7.4, 2mM CaCl2, 1mM MgCl2, 10mM glucose) at 37°C (Tokai 
Hit Chamber).  Electrical stimulation is triggered by 1ms current injections with a 
concentric bipolar electrode (FHC) placed 50-100μm away from transfected neuronal cell 
bodies for stimulating nearby axons. We applied 20APs (10Hz) with 30V using the 
stimulator (Model 2100, A-M systems) and imaged with 500ms interval (2Hz) during 
90sec for G-CEPIA1er, mito-RCaMP1h, and cyto-RCaMP1h signals. For CEPIA3mt 
imaging, 100ms interval (10Hz) was applied during 40s. For blocking SERCA pump, 
NMDAR, or mGluR1, cyclopiazonic acid (CPA, 30µM for 5min; Tocris), APV (50µM 
for 3min; Tocris), or LY367385 (100µM for 10min; Sigma-Aldrich) were incubated, 
respectively.  
Images were analyzed using the NIS Elements software (Nikon) or a Fiji (Image J) plug-
in, Time Series Analyzer (v3.0). One small area of each Hela cell is selected by circular 
ROI by NIS Elements, and average intensities were measured with background 
correction. 2-3 dendritic segments (10µm) from a single neuron and nearby backgrounds 
were selected by ROIs and average intensities were measured by the plug-in. After 
intensities were corrected for background subtraction, ΔF values were calculated from 
(F-F0). F0 values were defined by averaging 10 frames before stimulation, and used for 
normalization. For Fmax values, ionomycin (5µM) were applied after stimulation and 
average intensity of 10 frames from a plateau was employed for normalization. 
TMRM imaging 
NIH3T3 cells were plated and transfected with pCAG-mitoYFP and either control 
plasmid (pLKO1) or pLOK1 vector expressing shRNA targeting Pdzd8 plasmids with 
FugeneHD (Promega). Cells were replated on glass bottom dishes (MatTek) at 1x104/cm2 
density and incubated for 1 day. After treatment with 20nM TMRM for 20min, the 
medium was replaced with Hank’s buffered salt solution (HBSS) supplemented with 
HEPES (pH7.4; 2.5mM), CaCl2 (2mM, Sigma), MgSO4 (1mM, Sigma), NaHCO3 (4mM, 
Sigma), and D-glucose (30mM, Sigma) and 5nM TMRM. Cells were imaged with 60x 
(1.4 NA) oil objective on a Nikon Ti-e inverted microscope equipped with a Nikon A1 
confocal. To obtain eliminate mitochondrial membrane potential, cells were treated with 
0.3µM FCCP (Enzo Life Sciences) and 1µg/µl Oligomycin (Calbiochem). 
In utero cortical electroporation 
The in utero electroporation method was performed as previously described. Briefly, a 
mixture of the vectors pCAG Canx-YFP and pCAG mito (CoxVIII)-mtagBFP2 together 
with either control pLKO vector or pLKO-shPDZD8 were injected into the neocortical 
lateral horn of embryos obtained from a timed-pregnant CD1 mouse female at E15.5 with 
Picospritzer III (Parker, Hollis NH, USA). The cDNA mixtures were then electroporated 
into the neural progenitor cells resided in the ventricular zone by 5 electric pulses (50ms) 
of 38V using Tweezer-type platinum electrode (diameter 3mm; NEPA GENE) and an 
electroporation system ECM 830 (BTX, Holliston MA, USA). 
In situ hybridization 
In situ hybridization was performed as previously described (64). The probes for PDZD8 
was generated with the following primers;  
5’- GCGAATTAACCCTCACTAAAGGGTTCCTTCAGAAAGTTCTGCTCC -3’ 
5’- GCGTAATACGACTCACTATAGGGGTCTATTCGCCTCTCAGTTGCT -3’  
 
 
Fig. S1 Tertiary, secondary and primary sequence alignment between the SMP 
domain of PDZD8 and other SMP domains. 
(A, B) Superimposition of Phyre2 homology models for the SMP domains of Mmm1 
(green-blue in A,B) over templates from the crystal structures of either E-Syt2 (white in 
A, 192-370 a.a.; PDB code 4P42) or Mdm12 (white in B, 1-266 a.a.; PDB code 5gyk). 
(C) Predicted secondary structure of the SMP domain of Mmm1 (S. cerevisiae) aligned 
with the secondary structure of E-Syt2 (human) and Mdm12 (S. cerevisiae), another SMP 
domain-containing protein found in the ERMES complex. (D) Secondary structural 
alignment of a.a. sequences corresponding to the SMP domains of yeast MMM1 and 
mouse Pdzd8. Predicted secondary structures are shown below the a.a. sequence. Loop 
regions (L1 and L2) are highlighted by red boxes and show absence of conservation 
between the two sequences. (E) Primary a.a. sequences of PDZD8 SMP domains from 
indicated species are aligned. Red, blue, and black characters indicate 100%, >50%, 
Hirabayashi et al. 








































   -----HHHHHHHHHHHHHHHHCCHHHH--HHHHHHHHHHHHHHHHHH--C-CHHHCCEEEEEEECCCCCCCEEEEEEEECCC-CCHHCCCCCCCCCCCCCCCCCCEEEEEEEEEECCCCEEEEEEEEEECCC
1- -----LDWFNVLVAQIIQQF------RSEAWHRDNILHSLNDFIGRKSPDLPE-YLDTIKITELDTGDDFPIFSNCRIQYSPNS------------------GNKKLEAKIDIDLNDHLTLGVETKLLLNYP -102
   -----HHHHHHHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHCCCCCCC-CCCEEEEEECCCCCCCCEEEEEEEECCCCC------------------CCCCEEEEEEEEECCCCEEEEEEEEEECCC
127- --------AYLFVKLSRVVGRLRFVLTRVPFT-------------------HWFFSFVEDPLIDFEVRSQ----FEGRPMPQLTSIIVNQLKKIIKRKHTLPSYKIRFKP -200
     --------EEEEEEEEEEEEEEEEEECCCCCC-------------------EEEEEECCCCCEEEEEEEE----CCCCCCCCHHHHHHHHHHHHHHHEEECCCCEEEECC
103- KPGIAALPINLVVSIVRFQACLTVSLTNAEEFASTSNGSSSENGMEGNSGYFLMFSFSPEYRMEFEIKSLIGSRSKLENIPKIGSVIEYQIKKWFVERCVEPRFQFVRLP -212
     CCCCEEEEEEEEEEEEEEEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCEEEEEEEECCCCCHHHHCCHHHHHHHHHHHHHHHHHHHCCCCCEEEECC
L1
L2









Human       PTRETCYFLNATILFLFRELRDTALTRRWVTKKIKVEFEELLQTKTAGRLLEGLSLRDVFLGETVPFIKTIRLVRPVVPSATGEPDGPEGEALPAACPEELAFEAEVEYNGG 
Mouse       PTLETCYFLNATILFLFRELRDTALARRWVTKKIKVEFEELLQTKTAGRLLEGLSLRDVFLGDTVPFIKTIRLVRPVVASGTGEPDDPDGDALPATCPEELAFEAEVEYNGG 
Rat         PTLETCYFLNATILFLFRELRDTALARRWVTKKIKVEFEELLQTKTAGRLLEGLSLRDVFLGDTVPYIKTIRLVRPVVASGTGEPDEPDGDALPATCPEELAFEAEVEYNGG 
Chicken     SSEETCHFLNAIFLFLFRELRDTALVRNWVTKKIKVEFEELLQTKMTGKVLEGLSLRDVYLGNVLPVFKAVRLIRPVVCSEEG-------------CPEELGFEVDLEYNGG 
Zebrafish   SKAETCDFLNAIILFLFRELRDTPVVRHWITKKIKVEFEELLQTKTAGRLLEGLSLRDVSLGNSVPVFKTARLMKPVAVNEDN-------------MPEELNFEVDLEYNGG 
Xenopus     PAAESCQFLNTIFLFLFRELRDTALLRRWLSKKIRVELEELLQSRTAGRLLEGLSLRDISLGEALPVFRSVRLLSAPG---EP-------------LPDELQFEMEMEYSGG
 
Human       FHLAIDVDLVFGKSAYLFVKLSRVVGRLRLVFTRVPFTHWFFSFVEDPLIDFEVRSQFEGRPMPQLTSIIVNQLKKIIKRKHTLPNYKIRFKP
Mouse       FHLAIDVDLVFGKSAYLFVKLSRVVGRLRFVLTRVPFTHWFFSFVEDPLIDFEVRSQFEGRPMPQLTSIIVNQLKKIIKRKHTLPSYKIRFKP
Rat         FHLAIDVDLVFGKSAYLFVKLSRVVGRLRFVLTRVPFTHWFFSFVEDPLIDFEVRSQFEGRPMPQLTSIIVNQLKKIIKRKHTLPSYKIRFKP
Chicken     FHLAIDADLVFGKSAYLFVKLSRVMGKLKLVFTRLPFTHWYFSFMDDPLIVFEVKSQFEGRPMPQLTSIIVNQFKKVIKRKHTLPNYKIRYKP
Zebrafish   FHLAIDVDLVFGKSAYLFVKMTRVAGRLKLQFTRMPFTHWSFSFLEDPLIDFEVKSQFEGRPLPQLTSIIVNQLKRVIKRKHTLPNYKIRYKP
Xenopus     CRLAIDVELVFGKSASLSVRLGRVIGRLRLVFSRLPFPHWAFCFLPDPTIDFHVQSQFEGRPMPQLTSIIVTQLKKVIKRKHTLPNYKIRYKP
Red   100% Conserved
Blue  >50% Conserved
Black ≤50% Conserved
L1
≤50% conservation of the a.a. residues among corresponding species, respectively. Note 
that L1 loop region (box) is not conserved across the vertebrate species. 
  
  
Fig. S2 PDZD8 is localized at ER in yeast and human cells. 
(A) Plasmid-borne PDZD8-Venus co-localizes with the ER-marker Pho88-TFP, but not 
the mitochondrial-matrix marker Cit1p-mCherry, both expressed from their endogenous 
loci. (B) Overexpressed HA-tagged PDZD8 localizes at the ER in HeLa cell co-
transfected with a plasmid expressing Canx-YFP (ER marker) and stained with anti-GFP 
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Fig. S3 Original SMP domain of PDZD8 is not sufficient to restore the yeast 
mmm1Δ defects. 
(A) Diagram detailing the experimental strategy. Diploid heterozygotes for 
mmm1Δ:KanMX and CIT1-mCherry:Hygromycin-B (for visualizing mitochondria) 
alleles were transformed with plasmids (pRESC) containing a URA3-selection marker 
and the endogenous MMM1-promoter sequence followed by particular cDNA rescue 
inserts. Tetrad dissection was performed and colonies selected for co-segregation of 
mmm1Δ, CIT1-mCherry and pRESC, and analyzed. pRESC was then shuffled out from 
rescue strains by growth on media containing 5-Fluoroorotic acid (5-FOA), which is 
toxic to URA3 expressing strains, and assessed for reversion to mmm1Δ phenotype. (B) 
Diagrams detailing particular rescue constructs (Mmm1-sequence in magenta shading). 
(C) Rescue of mmm1Δ phenotypes by several pRESC constructs was assessed. 
Representative images (3D opacity rendering) of nuclear (N in white) and mitochondrial 
(M in magenta) DNA (DAPI) and mitochondria (Cit1p-mCherry) in mmm1Δ strains 
containing pRESC expressing full-length MMM1 (pMMM1), pMMM1 cells after 5-FOA 
plasmid cure, empty pRESC plasmids; pRESC expressing an N-terminal fragment of 
PDZD8 containing its TM and SMP domain (pPDZD8TM-SMP), and MMM1 containing 
PDZD8-SMP domain (pMMM1SMP-PDZD8-Full). Cell outlines are shown in white.  
  
 
Fig. S4 PDZD8-SMP domain containing L1 and L2 loops from Mmm1 rescues the 
yeast mmm1Δ defects.  
(A) Diagrams detailing pMMM1SMP-PDZD8+L1L2 (left) and pMMM1SMP-Mdm12+L1 (right) 
rescue constructs (Mmm1-sequence in magenta shading). (B) Structural predictions 
generated by PDB search through Phyre2 for pMMM1SMP-PDZD8+L1L2 (left) and 
pMMM1SMP-Mdm12+L1 (right) chimera based on E-syt2 (4P42) template. (C) Primary a.a. 
sequence of Pdzd8+L1L2 (underlined black bold characters) is illustrated. (D) 
Hirabayashi et al. 
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Representative images (3D opacity rendering) of nuclear (N) and mitochondrial (M) 
DNA (DAPI) and mitochondria (Cit1p-mCherry) in WT, mmm1Δ, mmm1Δ rescue strains 
containing pMMM1-SMPPDZD8+L1L2, or pMMM1SMP-Mdm12+L1 plasmids and the same strain 
following plasmid removal with 5-FOA. Cell-outlines are shown in white. Mitochondria 
falling into Tubular (T), Spherical (S) and Fragment (F) morphology categories are 
indicated. (E) Proportion of cells (n>100) containing mtDNA (rho+) as identified by 
DAPI staining, and (F) mitochondrial inheritance dynamics as the proportion of small-to-
medium sized buds (n>60) containing mitochondrial Cit1-mCherry signal. (G) 
Quantitation of the proportion of mitochondrial objects in budding mother cells (n>100) 
falling into each mitochondrial morphological category as defined in Experimental 
Procedures. Statistical significance was determined by Fisher’s Exact Test for Count 




Fig. S5 Quantitative approaches for measurement of mitochondrial morphology in 
yeast 
(A) Volume and skeletal length (SkL) of mitochondrial objects in budding mother-cells 
were used to calculate the diameter (d) of an ideal cylinder with equal volume (V) and 
SkL as height (h). Based on this (d) was defined as the tubular diameter (TD) and (B) 
individual mitochondrial objects from WT and mmm1Δ cells were classified as tubular 
for SkL/TD>2.5 and as spherical for SkL/TD <2.5. (B,C) The classifier is unable to 
distinguish objects from WT and mmm1Δ cells with SkL<0.325µm according to tubular 
and spherical categories and small objects are classified as fragmented. (D) 
Representative WT cell expressing Cit1p-mCherry containing examples of all three 
categories; tubular (T), spherical (S), fragmented (F). Cell outlines are shown in white. 
Statistical significance was determined by Fisher’s Exact Test for Count Data. * p<0.05, 
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Fig. S6 Validation and analysis of Pdzd8-Venus knock-in Neuro2a cell line  
(A) Diagram describing the strategy for making Neuro2a-PDZD8-Venus cell line. (B-C) 
Western blot analysis using anti-PDZD8 antiserum (B) or GFP antibody (C) in PDZD8-
Venus-KI-Neuro2a cell line. Cell lysates were collected from control or PDZD8-Venus-
KI Neuro2a cells transfected with plasmids expressing either control or Pdzd8 shRNA. 
Arrowhead indicates bands corresponding to PDZD8-Venus fusion protein. (D) 
Immunoblot of subcellular fractionation from PDZD8-Venus knock-in Neuro2a (N2a) 
cells demonstrates the presence of PDZD8 in ER and MAM fractions. MAM fraction was 
isolated using a Percoll gradient, and immunoblot was performed with anti-GFP for 
PDZD8-Venus, anti-Calnexin for ER and MAM fraction, and anti-cytochrome C for 
mitochondrial fraction.  (E-H) Larger field of view for images detailed in Fig. 1F-I. 
PDZD8-Venus knock-in N2a cells were transfected with a plasmid expressing Calnexin-
mCherry (ER marker) and stained with anti-RFP, anti-GFP antibody, and anti-OXPHOS 
complex antibody (mitochondrial marker). The stained cells were imaged with 3D N-SIM.  
 
Fig. S7 Validation of Pdzd8 shRNA knockdown efficacy and PDZD8 knockout HeLa 
cells. 
(A) PDZD8 is absent in the PDZD8 KO HeLa cells. Cell lysates collected from control or 
PDZD8 KO HeLa cells were subjected to Western blotting with anti-PDZD8 and anti-
Actin antibodies. (B) Efficacy of knockdown using shRNA against mouse Pdzd8 in 
HEK293 cells measured by Western blot analysis (C). Cultured mouse cortical neurons 
were infected at 4DIV with lentivirus expressing either control or Pdzd8 shRNA and total 
RNA was extracted at 13DIV. The Pdzd8 mRNA amounts were quantified by 
quantitative RT-PCR and normalized by Actin mRNA levels. (D-J) PDZD8 KO 
decreases the rate of HeLa cell growth. Control or PDZD8 KO HeLa cells were plated at 
7.9 x 103 cells/cm2. (D-I) Representative images of the cells with nuclear staining are 
shown. (J) Cell density i.e. number of cells per region of interest was quantified at 12, 36 
and 60 hours after plating following longitudinal imaging from the same dishes (n=3). 
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Fig. S8 Localization of synthetic ER-mitochondria tethering construct and 
measurement of ER Ca2+ load and release in NIH3T3 cells. 
(A) Schematic of the synthetic tethering protein. Green oval; mitochondria targeting 
domain of mouse AKAP1, Red oval; ER targeting domain of yeast UBC6, Grey line; 
linker protein. OMM; outer mitochondrial membrane. (B) Subcellular localization of the 
synthetic tethering protein (mTagBFP2; blue) used in Figure 3 along with CEPIA3mt 
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and reveals strong overlap with both mitochondria and ER. (C-D) NIH3T3 cells were 
transfected with plasmids encoding ER-targeted GECI (G-CEPIA1er) together with 
either a control plasmid (Control) or a Pdzd8 shRNA plasmid. Cells were stimulated with 
200 µM ATP to induce ER Ca2+ release and changes in fluorescence from G-CEPIA1er 
were measured. (C) Changes of G-CEPIA1er fluorescence (∆F) from normalized by basal 
signals before ATP stimulation (F0) are shown. (D) Peak intensities of ∆F/F0 10 seconds 
after ATP stimulation are not significantly different between the control and Pdzd8 KD 
cells. n= 37 (Control), 23 (Pdzd8 KD). (E-F) Resting ER (E) and mitochondrial (F) Ca2+ 
levels are measured from basal signals (F0 i.e. prior to ATP stimulation) normalized by 
Fmax obtained following ionomycin (5µM) treatment which allows normalization for 
potential cell-to-cell variation in GECI expression levels. Resting Ca2+ levels are not 
significantly changed in Pdzd8 KD NIH3T3 cells compared to control cells. (E) n= 13 
(Control), 16 (Pdzd8 KD), (F) n= 35 (Control), 25 (Pdzd8 KD).  (D, F) n.s. p>0.05 





Fig. S9 Mitochondrial Ca2+ import machinery, membrane potential and other MAM 
proteins are not altered in PDZD8-depleted mammalian cells. 
(A-B) Mitochondrial Ca2+ uptake itself is intact in PDZD8 KD NIH3T3 cells. NIH3T3 
cells expressing CEPIA3mt were permeabilized with 2.5 µM digitonin and treated with 
SERCA inhibitor (CPA 20 µM) for 3 min allowing to measure directly mitochondrial 
Ca2+ uptake following application of 1mM Ca2+ (at 10sec). This uptake is purely 
dependent of MCU because it is completely abolished by application of MCU inhibitor 
(Ru360, 10µM). Slope of ∆F/F0 increase in the linear phase was calculated as an indicator 
for the speed of mitochondrial Ca2+ uptake which is dependent on combination of MCU 
expression level and MCU channel gating properties. The uptake speed was not 
significantly different between the control and Pdzd8 KD cell. n= 9 (Control), 12 (Pdzd8 
KD). Mann-Whitney test. (C-D) Mitochondrial membrane potential is maintained in 
Pdzd8 KD NIH3T3 cells. NIH3T3 cells expressing mito-YFP and either control or 
shPdzd8 plasmids were loaded with 20 nM TMRM for 20 min and were imaged for 1min 






























































































































































in the presence of 5 nM TMRM. Then, cells were treated with 0.3 µM FCCP (electron 
transport chain uncoupler) and 1µg/µl Oligomycin (ATPase blocker) for complete 
elimination of mitochondrial potential (used as baseline fluorescence for normalization). 
(C) Changes of TMRM fluorescence (∆F). ****p<0.0001 according to paired t-test. (D) 
Mitochondrial TMRM signals normalized by baseline show no difference between 
control and Pdzd8 KD cells. n= 17 (Control), 16 (Pdzd8 KD). Mann-Whitney test. (E-H) 
Expression of mitochondrial Ca2+ regulatory proteins and other tethering proteins are not 
changed in PDZD8 KO HeLa cells. Immunoblot of control and PDZD8 KO HeLa cells 
shows no significant difference in expression level of mitochondrial Ca2+ uptake proteins 
(VDAC1 and MCU) and other ER/mitochondria tethering components (PTPIP51 and 
VDAC1). n=3 blots, Mann-Whitney test. 
  
 
Fig. S10 In situ hybridization for Pdzd8 mRNA in the embryonic and adult mouse 
brain.  
Sections from brains of adult (A, B, D-K) or E14.5 C57Bl6 mouse embryos (C) were 
hybridized with either antisense (A, C, D-G) or sense probes (negative control, B, H-K) 
for mouse Pdzd8 mRNA. (A, B) Sagittal sections of adult brains. (C) Sagittal section of 
E14.5 embryo. (D-K) Regions of brain indicated. Arrows indicate dorsal root ganglia in 
(C), Purkinje cells in (F), and mitral cells in (G).  
Abbreviations: L, Layer; DG, Dentate gyrus; ML, Molecular layer; GL, Granule layer; 
OPL, Outer Plexiform Layer.  
  























D E F G
H I J K














Fig. S11 Normal structure and distribution of mitochondria and ER in dendrites of 
control and PDZD8-depleted layer 2/3 pyramidal neurons in vivo. 
Plasmids expressing COXVIII-mtagBFP2 (mitochondrial marker) and Canx-YFP (ER 
marker) with either control shRNA or Pdzd8 shRNA were electroporated into the 
neocortex using in utero cortical electroporation at E15.5 and examined by confocal 
microscopy at P21. The apical dendrites of layer 2/3 neurons in the primary 
somatosensory cortex (S1) were imaged (A, B). The squares in panels A-B indicate the 
regions shown at high magnification in C-H. The squares in C-H indicate the regions 
shown at high magnification in C’-H’. Maximum projection images from 7.2 µm (C-E), 
3.5 µm (C’-E’), 13.6 µm (F-H), and 4.25 µm (F’-H’) thick Z-stacks are shown.  
  







































Fig. S12 Pharmacological dissection of ER-mitochondria Ca2+ exchange evoked by 
synaptic stimulation in cortical pyramidal neurons. 
(A-F) ER Ca2+-depletion disrupts mitochondrial Ca2+ elevation during repetitive 
stimulation with 20APs at 10Hz. ER and mitochondrial Ca2+ dynamics were monitored 
using G-CEPIA1er and mito-RCaMP1h from the same cortical neurons (19-24DIV) 
before and after cyclopiazonic acid treatment (CPA, 30µM over 5min), which inhibits 
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). Inhibition of ER Ca2+ uptake blocks 
the replenishment of ER Ca2+ amount. Basal level of ER and mitochondrial Ca2+ is 
decreased after CPA treatment (C, F). This suggests that CPA treatment did not indirectly 
saturate mitochondrial Ca2+ concentration through store-operated Ca2+ entry (SOCE) in 



































































































































































































dendrites. The modest but significant decreased in basal mitochondrial Ca2+ levels 
following CPA treatment cannot explain the almost complete disappearance of 
stimulation evoked mitochondrial Ca2+ increase observed in A-B.  n=27 dendritic 
segments from 9 neurons. ****p<0.0001, Wilcoxon matched pairs signed rank test. (G-J) 
NMDA receptor-dependent Ca2+ influx is required for triggering ER Ca2+ release and 
mitochondrial Ca2+ influx upon stimulation with 20APs-10Hz. Neurons were imaged 
before and after NMDA receptor blocker, APV, application (50µM). APV treatment 
abolished ER Ca2+ release (G, H) and mitochondrial Ca2+ increase (I, J). n=16 dendritic 
segments from 5 neurons. ****p<0.0001, Paired t test. (K-N) Acute inhibition of 
mGluR1 by LY367385 (100µM applied 10 min before and during imaging) disrupts ER 
Ca2+ release and mitochondrial Ca2+ uptake during synaptic stimulation (20APs at 10Hz). 
n=22 dendritic segments from 8 neurons. ****p<0.0001, Wilcoxon matched pairs signed 
rank test.  
  
 
Fig. S13 Mitochondrial Ca2+ import machinery and other tethering components are 
not altered in Pdzd8 knockdown cortical neurons. 
(A-D) Expression of mitochondrial Ca2+ regulatory proteins and other tethering proteins 
are not changed in Pdzd8 KD neurons. Cultured neurons were infected at 4DIV with 
lentivirus expressing either control shRNA or Pdzd8 shRNA and cells were lysed at 
14DIV. Immunoblot of control and PDZD8 KO neurons shows no difference in 
expression level of mitochondrial Ca2+ uptake proteins (VDAC1 and MCU) and other 
ER-mitochondria tethering components (PTPIP51 and VDAC1; n=3 independent 
immunoblots). (E-H) Mitochondrial Ca2+ uptake and extrusion kinetics are not affected 
by Pdzd8 KD. Mitochondrial Ca2+ dynamics was monitored using CEPIA3mt at 21-
22DIV with 20APs. We employed CEPIA3mt for measuring more precisely 
mitochondrial Ca2+ kinetics because of its lower Ca2+ affinity (Kd=11µM) compared to 
mito-RCaMPh1 (Kd=1.3µM), and thus to minimize saturation in some cells following 
synaptic stimulation. Images were captured with 100ms interval. Time to peak and decay 





















































































































































































neurons, but peak of the CEPIA3mt signals is significantly reduced (by ~40%). n= 57 
dendritic segments from 26 neurons for control, and 67 dendritic segments from 27 
neurons for Pdzd8 KD. (I-J) Resting level Ca2+ of mitochondria and ER are not changed 
in Pdzd8 KD neurons. Somatic CEPIA3mt and dendritic G-CEPIA1er signals were 
measured before (for F0) and after ionomycin treatment (for Fmax). Normalized baseline 
signals (F0/ Fmax) showed no significant difference between control and PDZD8-deficient 
neurons. n=7 neurons for control and 9 neurons for Pdzd8 KD in somatic CEPIA3mt 
analysis. n=38 dendritic segments from 14 neurons for control and 32 dendritic segments 
from 13 neurons for Pdzd8 KD in dendritic G-GCEPIA1er analysis. Statistical 




Captions for Movies S1-S9 
 
Movie S1. Serial z-stack images of Pdzd8-venus knock-in N2a cells. 
The cell shown in Figures 1 and S6 (E-H) was imaged using 3D N-SIM (step size 0.12 
µm, 20 sections) showing predominant colocalization of PDZD8-Venus with ER (red, 
Calnexin-mCherry). See legend of Figure 1 for details. 
 
Movies S2 and S3. 3D FIB-SEM image series and animation showing reconstructed 
ER, mitochondria and ER-mitochondria contacts of control HeLa cells.  
Serial EM images (20 nm interval, 100 sections for Movie 2, 83 sections for Movie 3) 
from areas enriched with sheet-like ER (Movie 2) or tubular ER (Movie 3), obtained by 
FIB-SEM of control HeLa cells are shown. The mitochondria and ER were labeled with 
green and magenta, respectively. This is merged with the 3-dimensional distribution of 
mitochondria (green) and ER (magenta), followed by display of only ER-mitochondria 
contact sites labeled in magenta on the last frames. See text for details. 
 
Movies S4 and S5. 3D-SEM image series and animation showing reconstructed ER, 
mitochondria and ER-mitochondria contacts in PDZD8 KO HeLa cells.  
Serial FIB-SEM images (20 nm interval, 38 sections for Movie 4, 75 sections for Movie 
5) from areas enriched with sheet-like ER (Movie 4) or tubular ER (Movie 5) obtained 
by FIB-SEM of PDZD8-KO HeLa cells are shown. The mitochondria and ER were 
labeled with green and magenta, respectively. This is merged with the 3-dimensional 
distribution of mitochondria (green) and ER (magenta), followed by display of only ER-
mitochondria contact sites labeled in magenta on the last frames. See text for details. 
 
Movie S6. ATP-induced Ca2+ release from ER and transfer into mitochondria in 
control NIH3T3 cells. 
Representative time-lapse images of ER and mitochondrial Ca2+ dynamics before and 
after ATP stimulation. Cells are displayed in ratio view normalized by basal signals (F0) 
of each probe using R-CEPIA1er and G-CEPIA3mt. F/F0 values are plotted for the 
duration of the acquisition. See text for details. 
 
Movie. S7 ATP-induced Ca2+ release from ER and transfer into mitochondria in 
Pdzd8 KD NIH3T3 cells. 
Representative time-lapse images of ER and mitochondrial Ca2+ dynamics before and 
after ATP stimulation. Color range displayed as ratio of fluorescence value (F) 
normalized by basal signals (F0) of each probe (R-CEPIA1er and CEPIA3mt). Bottom 
panels: F/F0 values are plotted for the duration of the acquisition. See text for details. 
 
Movie. S8 Ca2+ transfer from ER to mitochondria upon synaptic stimulation in 
proximal dendrites of cortical pyramidal neuron expressing control shRNA. 
Representative time-lapse images of ER and mitochondrial Ca2+ dynamics before and 
after synaptic stimulation (20AP, 10Hz) in cortical neurons expressing control shRNA. 
Color range displayed as ratio of fluorescence values (F) normalized by basal signals (F0) 
for each probe (G-CEPIA1er and mito-RCaMP1h). Bottom panels: F/F0 values are 
plotted for the duration of the acquisition. See text for details. 
 
Movie. S9 Ca2+ transfer from ER to mitochondria upon synaptic stimulation in 
proximal dendrite of cortical pyramidal neuron expressing Pdzd8 shRNA. 
Representative time-lapse images of ER and mitochondrial Ca2+ dynamics before and 
after synaptic stimulation (20AP, 10Hz) expressing Pdzd8 shRNA. Color range displayed 
as ratio view normalized by basal signals (F/F0) for each probe (G-CEPIA1er and mito-
RCaMP1h). Bottom panels: F/F0 values are plotted for the duration of the acquisition. See 
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